Biofrontera- Warrants (27/10/2026) Debt to Equity

As of the most recent data, BFRIW shows a debt-to-equity ratio of 1.26. That is above the Healthcare sector average of 0.28. Scroll down for historical charts and peer comparison views.

The Healthcare sector average debt-to-equity ratio is about 0.28. Biofrontera- Warrants (27/10/2026) is at 1.26, which is higher that average. That is roughly 355.6% above the sector mean. Use the comparison chart on this page to see how BFRIW stacks up against individual peers as well.

Investors watch BFRIW's debt-to-equity ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Biofrontera- Warrants (27/10/2026)'s latest reading is 1.26. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this debt-to-equity ratio page, Stockcircle has Biofrontera- Warrants (27/10/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect debt-to-equity ratio (currently 1.26) with ownership activity and broader fundamentals.

The Healthcare average debt-to-equity ratio is about 0.28, while BFRIW is at 1.26. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.